Medical Marijuana Inc.

AXIM® Biotechnologies Takes Steps Toward Patenting CBD-Based Migraine Treatment

Medical Marijuana, Inc. investment AXIM® Biotechnologies looks to expand impressive intellectual property portfolio with patent on cannabinoid chewing gum for migraines. Leading cannabinoid research and new drug development company AXIM® Biotechnologies recently filed a provisional patent application with the United States Patent and Trademark Office (USPTO). The provisional patent application […]